News

November 30, 2023

ATAGI: Recommendations on the use of the Moderna and Pfizer monovalent Omicron XBB.1.5 COVID-19 vaccines

October 5, 2023

Australian Immunisation Handbook: New chapter on COVID-19

October 5, 2023

Misinterpretation and misuse of recent COVID-19 study

October 2, 2023

Decommission of COVID-19 Vaccination Training Program

September 21, 2023

BMJ: Considerations for vaccinating children against COVID-19

September 21, 2023

Updated monovalent mRNA COVID-19 vaccines approved by FDA

September 7, 2023

ATAGI: Update on the COVID-19 vaccination program

July 27, 2023

Medical Journal of Australia: Local research examines COVID’s impact on cancer patients

June 1, 2023

ATAGI advice on the preferential use of bivalent COVID-19 vaccines for primary vaccination of people aged 12 years or older

June 1, 2023

Updated immunisation reference page: COVID-19

May 4, 2023

All Spikevax (Moderna) COVID-19 vaccines for children 6 months-5 years have now expired

May 4, 2023

Updated immunisation reference page: Immunosuppression and vaccines

April 27, 2023

TGA: Moderna’s COVID-19 vaccine SPIKEVAX receives approval for full registration

April 4, 2023

WHO SAGE: Updated Roadmap for prioritizing uses of COVID-19 vaccines

March 23, 2023

NCIRS: Recording of COVID-19 and influenza vaccination update 2023

March 16, 2023

New England Journal of Medicine Interview: What to expect from Covid-19 vaccines

February 19, 2023

NCIRS webinar – COVID-19 and influenza vaccination update 2023

February 9, 2023

ATAGI recommendations for COVID-19 booster doses in 2023